Sonoma Pharmaceuticals, Inc. (SNOA) › RevenueSonoma Pharmaceuticals, Inc. (SNOA) — RevenueAnnual figures by fiscal year, from SEC filings.2011: $9.75M2012: $12.74M2013: $15.45M2014: $13.67M2015: $13.85M2016: $9.37M2017: $12.82M2018: $16.66M2019: $18.97M2021: $18.63M2022: $12.63M2023: $13.27M2024: $12.73M2025: $14.29M2026: $19.53M$19.53M2011Revenue (USD)2026Fiscal YearRevenueChange YoY2026$19.53M+36.7%2025$14.29M+12.2%2024$12.73M-4.0%2023$13.27M+5.1%2022$12.63M-32.2%2021$18.63M—2019$18.97M+13.9%2018$16.66M+29.9%2017$12.82M+36.9%2016$9.37M-32.4%2015$13.85M+1.4%2014$13.67M-11.5%2013$15.45M+21.2%2012$12.74M+30.7%2011$9.75M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share